FOXM1 and non-small cell lung carcinoma: In this study, we assessed the expression levels of FoxM1 using IHC staining in a cohort of 175 Chinese NSCLC patients and for first time demonstrated that elevated expression of FoxM1 was correlated with several clinicopathological factors and predicted an unfavorable prognosis in NSCLC patients, including SCC and AC.